![Drug discovery / Phosphoinositide 3-kinase inhibitor / Phosphoinositide 3-kinase / Histone deacetylase / AKT / Multiple myeloma / T cell / CD40 / Hematological malignancy / Medicine / Hematologic neoplasms / Lymphoma Drug discovery / Phosphoinositide 3-kinase inhibitor / Phosphoinositide 3-kinase / Histone deacetylase / AKT / Multiple myeloma / T cell / CD40 / Hematological malignancy / Medicine / Hematologic neoplasms / Lymphoma](https://www.pdfsearch.io/img/e9ed04795b37d41338f2391481b54b40.jpg) Date: 2014-05-12 19:51:30Drug discovery Phosphoinositide 3-kinase inhibitor Phosphoinositide 3-kinase Histone deacetylase AKT Multiple myeloma T cell CD40 Hematological malignancy Medicine Hematologic neoplasms Lymphoma | | DUAL FUNCTION HDAC AND PI3K INHIBITOR CUDC-907 AFFECTS CANCER CELLS AND THE TUMOR MICROENVIRONMENT IN HEMATOLOGICAL MALIGNANCIES Inc., Lexington, MA; 2Department of Medicine, Memorial Sloan-Kettering Cancer Center, New Add to Reading ListSource URL: www.curis.comDownload Document from Source Website File Size: 1,49 MBShare Document on Facebook
|